Jennifer Silva
Family · South Windsor, CTNPI 1093252462
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (54.3%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. 30 manufacturers reported payments, led by AbbVie at 43.6% of the total. Among family clinicians in CT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 977 payments — averaging $92.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$39K
- Lilly USA, LLC$19K
- Pfizer$6K
- Incyte Corporation$6K
- Eli Lilly$5K
- Sanofi$3K
- plus $12K from 24 others
What the payments were for
- Consulting fees$11,61313%
- Speaking & faculty fees$49,14054%
- Travel & lodging$8,1959%
- Food & beverage$20,91523%
- Education$6911%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 258 | $39,475 |
| Lilly USA, LLC | 110 | $19,252 |
| Pfizer | 74 | $6,270 |
| Incyte Corporation | 89 | $5,814 |
| Eli Lilly | 10 | $5,263 |
| Sanofi | 37 | $2,867 |
| LEO Pharma Inc. | 67 | $2,200 |
| Johnson & Johnson | 58 | $2,104 |
| Regeneron Healthcare Solutions, Inc. | 38 | $1,142 |
| Medimetriks Pharmaceuticals, Inc. | 4 | $988 |
| Arcutis Biotherapeutics, Inc. | 57 | $864 |
| E.r. Squibb & Sons, L.L.C. | 48 | $676 |
| Dermavant Sciences, Inc. | 28 | $565 |
| Sun Pharmaceutical Industries Inc. | 17 | $539 |
| UCB, Inc. | 18 | $384 |
| Amgen | 10 | $373 |
| Novartis | 11 | $293 |
| Galderma Laboratories, L.p. | 11 | $239 |
| AstraZeneca | 2 | $202 |
| Inari Medical, Inc. | 1 | $179 |
| Organon | 5 | $154 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 7 | $133 |
| VYNE Pharmaceuticals Inc. | 1 | $125 |
| EPI Health, LLC | 6 | $117 |
| Journey Medical Corporation | 1 | $114 |
| Botanix SB Inc | 5 | $97 |
| Sanofi-aventis U.S. LLC | 1 | $55 |
| Convatec Inc. | 1 | $30 |
| Almirall LLC | 1 | $24 |
| Smith+Nephew | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Rinvoq$18,522
- OLUMIANT$16,200
- Skyrizi$15,715
- CIBINQO$5,056
- EBGLYSS$3,150
- DUPIXENT$1,986
- Neo-Synalar$988
- Clindacin ETZ$738
- ADBRY$726
- Tremfya$386
- Genadur$250
- ILUMYA$180
- FLOWTRIEVER CATHETER, S$179
- CT THROMBECTOMY SYSTEM KIT$179
- VTAMA$140
- AMZEEQ$125
- TEZSPIRE$125
- LITFULO$125
- Otezla$122
- LIBTAYO$122
How this compares
$90,553 in reported general payments places this provider in the 95th percentile of 1,596 family providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Skyrizi PenRisankizumab-Rzaa | 14 | $291,923 |
| Dupixent PenDupilumab | 32 | $126,565 |
| Pimecrolimus | 32 | $8,226 |
| Fluorouracil | 50 | $3,535 |
| Ketoconazole | 152 | $1,920 |
| Tacrolimus | 16 | $1,839 |
| Tretinoin | 29 | $1,347 |
| Metronidazole | 27 | $1,273 |
| Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc | 113 | $1,146 |
| Triamcinolone Acetonide | 111 | $1,143 |
| Azelaic Acid | 12 | $1,019 |
| Clobetasol Propionate | 19 | $713 |
| Mupirocin | 54 | $462 |
| Doxycycline Hyclate | 32 | $435 |
| Ciclopirox | 14 | $422 |
Paid to pharmacies, not to this prescriber.
Other family in South Windsor
- Farhiya AbdiSouth Windsor$30K
- Elisha ChristiansonWaterbury$371K
- Kathryn TierneyNew Britain$140K
- Carli WillardEnfield$74K
- Erin MartinMilford$70K
- Dayna GiordanoNew Haven$65K
- Diana BytyqiDerby$53K
- Nicole SandilandsBridgeport$30K
- Ralph HirschfeldPutnam$26K
- David OhotnickyTorrington$24K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.